Cargando…

Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate

BACKGROUND: Progressive multifocal leukoencephalopathy (PML), a potentially fatal demyelinating disease caused by the John Cunningham virus (JCV), can occur as a complication of treatment with rituximab, fingolimod, and dimethyl fumarate. The primary objective of this study was to determine changes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farley, Stephen, Gottesman, Malcolm H., Friedman-Urevich, Sharon, Ye, Janin, Shen, Mark, Grueneberg, Denise, Martone, Lorraine, Calixte, Rose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Scholar 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743681/ https://www.ncbi.nlm.nih.gov/pubmed/31528397 http://dx.doi.org/10.25259/SNI-4-2019

Ejemplares similares

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2020)

John Cunningham
Publicado: (1919)

Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis
por: Hou, Jue, et al.
Publicado: (2021)

Daniel John Cunningham
Publicado: (1909)

Johns and Cunningham’s the Physics of Radiology
por: Sharma, Sunil Dutt
Publicado: (2021)

Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate
por: Mathias, Amandine, et al.
Publicado: (2017)

Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
Publicado: (2018)

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
por: Vollmer, Brandi, et al.
Publicado: (2018)

Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
por: Nakhaei-Nejad, Maryam, et al.
Publicado: (2017)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2018)

A Case of John Cunningham Virus Induced Rhombencephalitis after Rituximab Therapy for Idiopathic Thrombocytopenic Purpura
por: Katragadda, Silpita, et al.
Publicado: (2021)

The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
por: Wicks, Paul, et al.
Publicado: (2016)

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
por: Lorscheider, Johannes, et al.
Publicado: (2020)

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
por: Vollmer, Brandi, et al.
Publicado: (2017)

HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis
por: Blumenfeld Kan, S, et al.
Publicado: (2019)

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
por: Diem, Lara, et al.
Publicado: (2020)

The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosis
por: Reynolds, Audrey, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy secondary to rituximab-induced immunosuppression and the presence of John Cunningham virus: a case report and literature review
por: Kelly, Deirdre, et al.
Publicado: (2016)

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up
por: Hersh, Carrie M, et al.
Publicado: (2017)

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models
por: Rupp, Tristan, et al.
Publicado: (2022)

Kidney Allograft Dysfunction Due to John Cunningham (JC) Virus Nephropathy
por: Sharma, Neeraj, et al.
Publicado: (2022)

Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod
por: Hersh, Carrie M, et al.
Publicado: (2020)

Increased multiple sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate: a case series
por: Delgado, Silvia, et al.
Publicado: (2021)

Mapping the history and current situation of research on John Cunningham virus – a bibliometric analysis
por: Zheng, Hua-chuan, et al.
Publicado: (2009)

Conversion and reversion of anti‐John Cunningham virus antibody serostatus: A prospective study
por: Auer, Michael, et al.
Publicado: (2019)

A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod
por: Salter, Amber, et al.
Publicado: (2021)

COS-7-based model: methodological approach to study John Cunningham virus replication cycle
por: Prezioso, C., et al.
Publicado: (2018)

High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis
por: Kim, Su-Hyun, et al.
Publicado: (2019)

Erratum to “A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod”
Publicado: (2021)

CUNNINGHAM'S TEXTBOOK OF ANATOMY
Publicado: (1965)

CUNNINGHAM'S TEXTBOOK OF ANATOMY
Publicado: (1972)

Cunningham's Textbook of Anatomy
por: Crelin, E. S.
Publicado: (1965)

Cunningham, fisiología veterinaria /
Publicado: (2020)

Cunningham, fisiología veterinaria /
Publicado: (2014)

Cunningham and the "Daily Express"
Publicado: (1901)

Cunningham's Textbook of Anatomy
Publicado: (1937)

Reliability of the Cunningham Panel
por: Frye, Richard E., et al.
Publicado: (2019)

Genotypes of John Cunningham (JC) Virus Urinary Excretion in Pregnant and Non-Pregnant Women in Isfahan, Iran
por: Atyabi, Sayyedeh Rahmaneh, et al.
Publicado: (2018)

Erratum to: High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis
por: Kim, Su-Hyun, et al.
Publicado: (2020)

Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
por: Sgarlata, Eleonora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aghvqmkqlqj6c9u6surq1se5e6